Global Telehealth Market Size, Share and Trends, 2026-2033 | Market to Reach USD 187.5 Billion as AI, Cloud and Remote Patient Monitoring Unlock Growth Opportunities
Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Telehealth Market Size, Share & Trends Analysis Report by Product Type, Delivery Mode, Disease Area, End Use, Region, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.
The global telehealth market was valued at USD 77.4 billion in 2025 and is projected to increase from USD 87.7 billion in 2026 to USD 187.5 billion by 2033. The market is expected to expand at a compound annual growth rate of 11.5% from 2026 to 2033, supported by the continued integration of digital technologies across healthcare systems.
Key telehealth market growth drivers include increasing digital health and smartphone adoption, improved internet connectivity, technological advancements, and rising investment in healthcare IT infrastructure. Greater demand for remote healthcare services is also encouraging healthcare providers, payers, and technology companies to expand virtual care capabilities and improve access to clinical services.
The increasing prevalence of chronic diseases is strengthening demand for virtual consultations and remote patient monitoring. These services enable healthcare organizations to maintain ongoing engagement with patients while supporting efficient care delivery across multiple disease areas. Telehealth platforms are also gaining importance in underserved and rural communities, where access to healthcare facilities and specialists may be limited.
North America led the global telehealth market with a revenue share of 45.2% in 2025. The region's leadership reflects strong digital health adoption, established healthcare technology infrastructure, supportive initiatives, and the growing acceptance of remote care models. The expanding presence of global and regional telehealth platform providers is further contributing to market development.
Government support for digital health implementation is expected to remain an important factor influencing industry expansion. Public and private investment in connected healthcare infrastructure, virtual consultation platforms, and patient monitoring technologies is creating opportunities for scalable telehealth deployment. These developments are helping healthcare stakeholders address accessibility requirements while supporting more flexible models of care.
Recent initiatives demonstrate the widening application of telehealth technology. In November 2024, the Canadian Space Agency, in partnership with Baune, introduced a telehealth station at the CLSC in Pierrefonds on Montreal's West Island. The station allows astronauts and patients to measure and monitor pulse, blood pressure, and blood oxygen levels, highlighting the potential for connected health technologies to support monitoring in specialized and community-based settings.
The report analyzes revenue growth at the global, regional, and country levels and evaluates industry trends across key sub-segments from 2021 to 2033. Market segmentation covers product type, delivery mode, end use, disease area, and region, providing insight into the technologies, users, clinical applications, and geographic markets shaping industry growth.
Product Type Outlook - Revenue, USD Billion, 2021-2033
Software and services are central to the delivery and management of virtual care, while hardware supports patient monitoring, communication, and connected clinical workflows.
Delivery Mode Outlook - Revenue, USD Billion, 2021-2033
The availability of multiple delivery models enables healthcare organizations to select telehealth infrastructure based on operational requirements, security considerations, scalability, and existing IT environments.
End Use Outlook - Revenue, USD Billion, 2021-2033
Disease Area Outlook - Revenue, USD Billion, 2021-2033
The broad range of disease areas reflects the growing role of telehealth in consultations, follow-up care, diagnostics, specialist access, and long-term patient management.
Regional Outlook - Revenue, USD Billion, 2021-2033
Across these regions, market opportunities will be influenced by digital infrastructure, healthcare access, regulatory support, technology investment, and the adoption of virtual care by patients and medical professionals. Continued innovation and broader deployment are expected to strengthen the role of telehealth within global healthcare delivery through 2033.
Key Topics Covered:
Chapter 1. Methodology and scope
1.1. Market segmentation & scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research methodology
1.3. Information procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or data analysis
1.4.1. Data analysis models
1.5. Market formulation & validation
1.6. Model details
1.6.1. Multi-lens modeling framework (model 1)
1.6.2. Commodity flow analysis (model 2)
1.6.3. Regional & country-level estimation
1.6.4. Segment level market size estimates - top-down
1.6.5. Segment share calculation
1.6.6. CAGR estimation and forecast factors
1.7. Research assumptions
1.8. List of secondary sources
1.9. List of primary sources
Chapter 2. Executive summary
2.1. Market outlook
2.2. Segment outlook
2.2.1. Product outlook
2.2.2. Delivery mode outlook
2.2.3. Disease area outlook
2.2.4. End use outlook
2.2.5. Regional outlook
2.3. Competitive insights
Chapter 3. Telehealth market variables, trends & scope
3.1. Market lineage outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing adoption of digital health technologies
3.2.1.2. Shortage of medical professionals and increasing demand for healthcare services
3.2.1.3. High penetration of smartphones
3.2.1.4. Expanding integration with wearable devices and electronic health records
3.2.2. Market restraint analysis
3.2.2.1. Cybersecurity and privacy concerns
3.2.2.2. Lack of healthcare infrastructure in developing regions
3.3. Telehealth: market analysis tools
3.3.1. Industry analysis - Porter's Five Forces Analysis
3.3.2. Pestle analysis
3.4. Telehealth adoption rate (%)
3.5. Technology landscape
3.6. Funding scenario
3.7. Case study analysis
3.8. Use Case 1: Tele-Psychiatry for mental health support in chronic disease patients
3.9. Use Case 2: Telemedicine for diabetes management (remote glycemic monitoring program)
3.10. Use Case 3: AI-enabled remote monitoring for cardiac risk management
3.11. Use Case 4: Remote COPD care and digital pulmonary rehabilitation
3.12. Integration Trends Between Telehealth and Pharma
3.13. Regulatory And Reimbursement Shifts Impacting Remote Prescribing And Therapy Adherence Solutions
3.14. Key evaluation matrix, by key 40 companies 2021 - 2031
3.14.1. Monthly active users
3.14.1.1. Leaders
3.14.1.2. Challengers
3.14.1.3. Innovators
3.14.1.4. Emerging players
3.14.2. Paid users
3.14.2.1. Leaders
3.14.2.2. Challengers
3.14.2.3. Innovators
3.14.2.4. Emerging players
Chapter 4. Telehealth market segment analysis, by product, 2021 - 2033 (USD Billion)
4.1. Definition and scope
4.2. Product market share analysis, 2025 & 2033
4.3. Segment dashboard
4.4. Global telehealth market, by product, 2021 to 2033
4.5. Hardware
4.5.1. Hardware market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.2. Monitors
4.5.2.1. Monitors market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3. Medical peripheral devices
4.5.3.1. Medical peripheral devices market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3.2. Blood pressure meters
4.5.3.2.1. Blood pressure meters market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3.3. Blood glucose meters
4.5.3.3.1. Blood glucose meters market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3.4. Weighing scales
4.5.3.4.1. Weighing scales market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3.5. Pulse oximeters
4.5.3.5.1. Pulse oximeters market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3.6. Peak flow meters
4.5.3.6.1. Peak flow meters market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3.7. ECG monitors
4.5.3.7.1. ECG monitors market estimates and forecasts, 2021 to 2033 (USD Billion)
4.5.3.8. Others
4.5.3.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)
4.6. Software
4.6.1. Software market estimates and forecasts, 2021 to 2033 (USD Billion)
4.6.2. Standalone software
4.6.2.1. Standalone software market estimates and forecasts, 2021 to 2033 (USD Billion)
4.6.3. Integrated software
4.6.3.1. Integrated software market estimates and forecasts, 2021 to 2033 (USD Billion)
4.7. Services
4.7.1. Services market estimates and forecasts, 2021 to 2033 (USD Billion)
4.7.2. Remote patient monitoring
4.7.2.1. Remote patient monitoring market estimates and forecasts, 2021 to 2033 (USD Billion)
4.7.3. Real-time interactions
4.7.3.1. Real-time interactions market estimates and forecasts, 2021 to 2033 (USD Billion)
4.7.4. Store and forward
4.7.4.1. Store and forward market estimates and forecasts, 2021 to 2033 (USD Billion)
4.7.5. Others
4.7.5.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)
Chapter 5. Telehealth market segment analysis, by delivery mode, 2021 - 2033 (USD Billion)
5.1. Definition and scope
5.2. Delivery mode market share analysis, 2025 & 2033
5.3. Segment dashboard
5.4. Global telehealth market, by delivery mode, 2021 to 2033
5.5. On-premise
5.5.1. On-premise market estimates and forecasts, 2021 to 2033 (USD Billion)
5.6. Web-based
5.6.1. Web-based market estimates and forecasts, 2021 to 2033 (USD Billion)
5.7. Cloud-based
5.7.1. Cloud-based market estimates and forecasts, 2021 to 2033 (USD Billion)
Chapter 6. Telehealth market segment analysis, by disease area, 2021 - 2033 (USD Billion)
6.1. Definition and scope
6.2. Disease area market share analysis, 2025 & 2033
6.3. Segment dashboard
6.4. Global telehealth market, by disease area, 2021 to 2033
6.5. Psychiatry
6.5.1. Psychiatry market estimates and forecasts, 2021 to 2033 (USD Billion)
6.6. Substance use
6.6.1. Substance use market estimates and forecasts, 2021 to 2033 (USD Billion)
6.7. Radiology
6.7.1. Radiology market estimates and forecasts, 2021 to 2033 (USD Billion)
6.8. Endocrinology
6.8.1. Endocrinology market estimates and forecasts, 2021 to 2033 (USD Billion)
6.9. Dermatology
6.9.1. Dermatology market estimates and forecasts, 2021 to 2033 (USD Billion)
6.10. Gastroenterology
6.10.1. Gastroenterology market estimates and forecasts, 2021 to 2033 (USD Billion)
6.11. Neurological medicine
6.11.1. Neurological medicine market estimates and forecasts, 2021 to 2033 (USD Billion)
6.12. ENT
6.12.1. ENT market estimates and forecasts, 2021 to 2033 (USD Billion)
6.13. Cardiology
6.13.1. Cardiology market estimates and forecasts, 2021 to 2033 (USD Billion)
6.14. Oncology
6.14.1. Oncology market estimates and forecasts, 2021 to 2033 (USD Billion)
6.15. Dental
6.15.1. Dental market estimates and forecasts, 2021 to 2033 (USD Billion)
6.16. Gynecology
6.16.1. Gynecology market estimates and forecasts, 2021 to 2033 (USD Billion)
6.17. General medicine
6.17.1. General medicine market estimates and forecasts, 2021 to 2033 (USD Billion)
6.18. Others
6.18.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)
Chapter 7. Telehealth market segment analysis, by end use, 2021 - 2033 (USD Billion)
7.1. Definition and scope
7.2. End use market share analysis, 2025 & 2033
7.3. Segment dashboard
7.4. Global telehealth market, by end use, 2021 to 2033
7.5. Payers
7.5.1. Payers market estimates and forecasts, 2021 to 2033 (USD Billion)
7.6. Providers
7.6.1. Providers market estimates and forecasts, 2021 to 2033 (USD Billion)
7.7. Patients
7.7.1. Patients market estimates and forecasts, 2021 to 2033 (USD Billion)
Chapter 8. Telehealth market segment analysis, by region, 2021 - 2033 (USD Billion)
8.1. Regional market share analysis, 2025 & 2033
8.2. Regional market dashboard
8.3. Regional market snapshot
8.4. Telehealth market share by region, 2025 & 2033:
8.5. North America
8.5.1. North America telehealth market, 2021 - 2033 (USD Billion)
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory scenario
8.5.2.3. Competitive scenario
8.5.2.4. U.S. Telehealth market, 2021 - 2033 (USD Billion)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory scenario
8.5.3.3. Competitive scenario
8.5.3.4. Canada telehealth market, 2021 - 2033 (USD Billion)
8.5.4. Mexico
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory scenario
8.5.4.3. Competitive scenario
8.5.4.4. Mexico telehealth market, 2021 - 2033 (USD Billion)
8.6. Europe
8.6.1. Europe telehealth market, 2021 - 2033 (USD Billion)
8.6.2. Uk
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory scenario
8.6.2.3. Competitive scenario
8.6.2.4. UK telehealth market, 2021 - 2033 (USD Billion)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory scenario
8.6.3.3. Competitive scenario
8.6.3.4. Germany telehealth market, 2021 - 2033 (USD Billion)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory scenario
8.6.4.3. Competitive scenario
8.6.4.4. France telehealth market, 2021 - 2033 (USD Billion)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory scenario
8.6.5.3. Competitive scenario
8.6.5.4. Italy telehealth market, 2021 - 2033 (USD Billion)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory scenario
8.6.6.3. Competitive scenario
8.6.6.4. Spain telehealth market, 2021 - 2033 (USD Billion)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory scenario
8.6.7.3. Competitive scenario
8.6.7.4. Norway telehealth market, 2021 - 2033 (USD Billion)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory scenario
8.6.8.3. Competitive scenario
8.6.8.4. Sweden telehealth market, 2021 - 2033 (USD Billion)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory scenario
8.6.9.3. Competitive scenario
8.6.9.4. Denmark telehealth market, 2021 - 2033 (USD Billion)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory scenario
8.7.1.3. Competitive scenario
8.7.1.4. Japan telehealth market, 2021 - 2033 (USD Billion)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory scenario
8.7.2.3. Competitive scenario
8.7.2.4. China telehealth market, 2021 - 2033 (USD Billion)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory scenario
8.7.3.3. Competitive scenario
8.7.3.4. India telehealth market, 2021 - 2033 (USD Billion)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory scenario
8.7.4.3. Competitive scenario
8.7.4.4. Australia telehealth market, 2021 - 2033 (USD Billion)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory scenario
8.7.5.3. Competitive scenario
8.7.5.4. South Korea telehealth market, 2021 - 2033 (USD Billion)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory scenario
8.7.6.3. Competitive scenario
8.7.6.4. Thailand telehealth market, 2021 - 2033 (USD Billion)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory scenario
8.8.1.3. Competitive scenario
8.8.1.4. Brazil telehealth market, 2021 - 2033 (USD Billion)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory scenario
8.8.2.3. Competitive scenario
8.8.2.4. Argentina telehealth market, 2021 - 2033 (USD Billion)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory scenario
8.9.1.3. Competitive scenario
8.9.1.4. South Africa telehealth market, 2021 - 2033 (USD Billion)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory scenario
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia telehealth market, 2021 - 2033 (USD Billion)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory scenario
8.9.3.3. Competitive scenario
8.9.3.4. UAE telehealth market, 2021 - 2033 (USD Billion)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory scenario
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait telehealth market, 2021 - 2033 (USD Billion)
Chapter 9. Competitive landscape
9.1. Recent developments & impact analysis, by key market participants
9.2. Company categorization
9.3. Company profiles
9.3.1. Koninklijke Philips N.V.
9.3.1.1. Company overview
9.3.1.2. Financial performance
9.3.1.3. Product benchmarking
9.3.1.4. Strategic initiatives
9.3.2. GE Healthcare
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Product benchmarking
9.3.2.4. Strategic initiatives
9.3.3. Oracle (Cerner Corporation)
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Product benchmarking
9.3.3.4. Strategic initiatives
9.3.4. Siemens Healthineers AG
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Medtronic
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Teladoc Health, Inc.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. American Well
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Md Live
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Doctor On Demand
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Global Med
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
List of Tables [120]
List of Figures [117]
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/52cz8l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.